SIMLANDI is the first interchangeable high-concentration, citrate-free biosimilar to Humira® PARSIPPANY, N.J. & REYKJAVÍK, Iceland–(BUSINESS WIRE)–Teva…
Continue ReadingCategoría: Business Wire
Categoría agregada por el Plugin WPeMatico
HopSkipDrive Commends the Biden-Harris Administration’s Efforts to Combat Chronic Absenteeism in Schools
White House issues new fact sheet highlighting the need for more equitable access to school transportation…
Continue Reading
280 Earth, a Company That Removes CO2 From the Air, Announces First Direct Air Capture Plant in Oregon; Closes 50M Series B Funding Round
THE DALLES, Ore.–(BUSINESS WIRE)–280 Earth, Inc. today announced that it has completed construction and started operating…
Continue Reading
Canada Embedded Finance Business Report 2024: Market to Grow by 34.3% to Reach $4.28 Billion this Year – Investment Opportunity Forecasts to 2029 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Canada Embedded Finance Business and Investment Opportunities Databook – 75+ KPIs on Embedded Lending,…
Continue Reading
Divert, Inc. Announces Harrison, Ohio as the Site of a Future Integrated Diversion & Energy Facility
With support from key local corporate, economic and political stakeholders, the facility is expected to prevent…
Continue Reading
United Arab Emirates Embedded Finance Business Report 2024: Government Initiatives Create Favorable Regulatory Environment, Integrated Payment Gateways Fuel Expansion – Forecasts to 2029 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “United Arab Emirates Embedded Finance Business and Investment Opportunities Databook – 75+ KPIs on…
Continue ReadingOasis Response to Hokuetsu’s Announcement on Reducing Daio Paper Stake (Securities Code: 3865 JT)
www.HokuetsuCorpGov.com HONG KONG–(BUSINESS WIRE)–Oasis Management Company Ltd. (“Oasis”) is the manager to funds that beneficially own…
Continue Reading
New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
Late-breaking results from the Phase IIa COURSE trial provide insight into TEZSPIRE’s impact on COPD exacerbations…
Continue Reading
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis
Data presented for the first time today during late-breaking oral session at the American Thoracic Society…
Continue Reading
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
Savara’s Partner, Trillium Health LLC, Presented Data on the Laboratory Blood Test for Diagnosing aPAP LANGHORNE,…
Continue Reading